Anemia in ST-elevation myocardial infarction patients with markers of inadequate bone marrow response

Israel Medical Association Journal

Volumn 17, Issue 8, 2015, Pages 500-504

  Arbel, Yaron ^a,c   Milwidsky, Assi ^a,c   Finkelstein, Ariel ^a,c   Halkin, Amir ^a,c   Revivo, Miri ^a,c   Berliner, Shlomo ^a,c   Ellis, Martin ^b,c   Herz, Itzhak ^a,c   Keren, Gad ^a,c   Banai, Shmuel ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anemia; Bone marrow; Inflammation; ST elevation myocardial infarction (STEMI); White blood cells (WBC)

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FIBRINOGEN; IRON; TRANSFERRIN; BIOLOGICAL MARKER; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW DEPRESSION; COMPARATIVE STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE SURVEY; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RETICULOCYTE COUNT; RETICULOCYTE PRODUCTION INDEX; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE COUNT; BLOOD; BLOOD CELL COUNT; BONE MARROW; COMPLICATION; ELECTROCARDIOGRAPHY; INFLAMMATION; LEUKOCYTE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; REGISTER; RETICULOCYTE;

ADULT; AGED; ANEMIA; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BONE MARROW; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; HEMOGLOBINS; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REGISTRIES; RETICULOCYTES;

EID: 84940368241     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nikolsky E, Mehran R, Aymong ED, et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004; 94 (8): 1023-7.
2. Leshem-Rubinow E, Steinvil A, Zeltser D, et al. Association of angiotensinconverting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clin Proc 2012; 87 (12): 1189-95.
3. Rousseau M, Yan RT, Tan M, et al. Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring. Am J Cardiol 2010; 106 (10): 1417-22.
4. Arbel Y, Shacham Y, Ziv-Baran T, et al. Higher neutrophil/lymphocyte ratio is related to lower ejection fraction and higher long-term all-cause mortality in STelevation myocardial infarction patients. Can J Cardiol 2014; 30 (10): 1177-82.
5. Bertrand OF, Larose E, Rodes-Cabau J, et al. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting. Am J Cardiol 2010; 106 (2): 155-61.
6. Merono O, Cladellas M, Recasens L, et al. In-hospital acquired anemia in acute coronary syndrome. Predictors, in-hospital prognosis and one-year mortality. Rev Esp Cardiol 2012; 65 (8): 742-8 (English edn).
7. Ferreira M, Antonio N, Goncalves F, et al. Hemoglobin: simply a laboratory value or a powerful predictor of risk in patients with acute coronary syndrome? Rev Port Cardiol 2012; 31 (2): 121-31.
8. Aronson D, Dann EJ, Bonstein L, et al. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol 2008; 102 (2): 115-19.
9. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292 (13): 1555-62.
10. Singla I, Zahid M, Good CB, et al. Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. Am J Cardiol 2007; 99 (8): 1119-21.
11. Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 2010; 363 (12): 1146-55.
12. Arbel Y, Shacham Y, Finkelstein A, et al. Red blood cell distribution width (RDW) and long-term survival in patients with ST elevation myocardial infarction. Thromb Res 2014; 134 (5): 976-9
13. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33 (20): 2569-619.
14. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
15. Riley RS, Ben-Ezra JM, Goel R, et al. Reticulocytes and reticulocyte enumeration. J Clin Lab Anal 2001; 15 (5): 267-94.
16. Lipschitz DA, Mitchell CO, Thompson C. The anemia of senescence. Am J Hematol 1981; 11 (1): 47-54.
17. Chen J, Jin J, Song M, et al. C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products. Gene 2012; 496 (2): 128-35.
18. Desouza CV, Hamel FG, Bidasee K, et al. Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 2011; 60 (4): 1286-94.
19. Jialal I, Devaraj S, Singh U, et al. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis 2010; 211 (1): 297-302.
20. Abou-Saleh H, Yacoub D, Theoret JF, et al. Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation 2009; 120 (22): 2230-9.
21. Padfield GJ, Newby DE, Mills NL. Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol 2010; 55 (15): 1553-65.
22. Pelliccia F, Cianfrocca C, Rosano G, et al. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc Interv 2005; 3 (1): 78-86.
23. Moreno PR, Sanz J, Fuster V. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol 2009; 53 (25): 2315-23.
24. Lee KW, Lip GY, Tayebjee M, et al. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105 (2): 526-32.
25. Kissel CK, Lehmann R, Assmus B, et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007; 49 (24): 2341-9.